---
title: "Integra LifeSciences names Robert T. Davis Jr. EVP, Tissue Reconstruction and Distributed Technologies"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290560020.md"
description: "Integra LifeSciences has reshuffled its commercial leadership. Robert T. Davis Jr. was named Executive Vice President of Tissue Reconstruction and Distributed Technologies. Mike McBreen became EVP and Chief Commercial Officer, with international leaders reporting to him. Christopher Kilburn-Peterson was promoted to Corporate Vice President and President of Tissue Reconstruction, while Harvinder Singh was appointed EVP and President of Specialty Surgery."
datetime: "2026-06-23T12:03:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290560020.md)
  - [en](https://longbridge.com/en/news/290560020.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290560020.md)
generator: "portal-rs"
---

# Integra LifeSciences names Robert T. Davis Jr. EVP, Tissue Reconstruction and Distributed Technologies

-   Integra LifeSciences reshuffled its commercial leadership following Mike McBreen’s appointment as executive vice president, chief commercial officer. \* Robert T. Davis Jr. named executive vice president, Tissue Reconstruction and Distributed Technologies, overseeing wound reconstruction, soft tissue, private label. \* Christopher Kilburn-Peterson promoted to corporate vice president, president of Tissue Reconstruction; previously senior vice president, general manager of Acclarent. \* Harvinder Singh appointed executive vice president, president of Specialty Surgery; previously led the international business. \* International regional leaders will now report directly to McBreen under the re-aligned commercial organization. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606230800PRIMZONEFULLFEED9750608) on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [IART.US](https://longbridge.com/en/quote/IART.US.md)

## Related News & Research

- [Sofwave says PlyoPulse EMS trial shows sustained gains in functional muscle performance](https://longbridge.com/en/news/297513105.md)
- [Bridgford consultant Allan Bridgford Jr acquires Bridgford Foods shares worth $6,140.36](https://longbridge.com/en/news/297934952.md)
- [SS Innovations International (NASDAQ: SSII) Indian Surgical Robotics Growth Points to Broader Market Opportunity](https://longbridge.com/en/news/297353255.md)
- [Agree Realty director John Rakolta Jr acquires $724,200 in common shares](https://longbridge.com/en/news/297823799.md)
- [Beeline CEO Nicholas Liuzza Jr buys USD 259,732 of common shares](https://longbridge.com/en/news/297560559.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**